Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug combinations
Pharma
Roche’s bispecific-ADC combo keeps lymphoma at bay
The positive Lunsumio-Polivy readout could give Roche another shot at second-line LBCL as its Columvi contends with a regulatory setback.
Angus Liu
Jun 23, 2025 10:27am
Roche bolsters Perjeta's case with ten-year breast cancer data
May 13, 2025 11:23am
BMS' schizophrenia drug stumbles in blow to blockbuster plan
Apr 23, 2025 10:35am
Gilead's Trodelvy-Keytruda proposal hits goal in first-line TNBC
Apr 21, 2025 11:29am
GSK kicks off Blenrep's market return with first combo nod in UK
Apr 17, 2025 2:29pm
BMS follows Roche, AstraZeneca into first-line liver cancer
Apr 11, 2025 1:53pm
